Search

You searched for "legislation"

2780 results found

Major grant secured to transform immune cell imaging research

5 June 2025 | NIHR, advanced imaging technology, Treatment, ophthalmology, research, news, Imaging
A research team has been awarded significant funding by the National Institute for Health and Care Research (NIHR) to develop an innovative drug-device combination that aims to revolutionise how individual immune cells are monitored and treated in patients at Moorfields...
American Journal of Ophthalmology cover image.

Intravitreal afibercept and ranibizumab for PCV

1 August 2016 | | EYE - Vitreo-Retinal
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...
American Journal of Ophthalmology cover image.

What effects do repeated Ozurdex implants have in paediatric uveitis?

1 April 2016 | | EYE - Paediatrics, EYE - Strabismus
The aim of this retrospective study was to assess the anatomical and functional results, as well as complications of repeated Ozurdex intravitreal implants in a paediatric (non-infectious) uveitis cohort. Twenty-two eyes (16 patients) received 35 Ozurdex implants over a six...
Ophthalmologica journal cover image.

Post hoc analysis of the CANTREAT randomised trial

1 December 2023 | | EYE - Vitreo-Retinal | Age-related macular degeneration, Randomized clinical trial, Ranibizumab, Treat-and-extend
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...
Ophthalmologica journal front cover image.

Intravitreal Aflibercept (IVT-AFL): treatment of macular oedema secondary to RVO

2 December 2025 | | EYE - Vitreo-Retinal
This paper is a sub-group analysis of the real-world effectiveness, treatment patterns, and safety of IVT-AFL in patients with macular oedema secondary to retinal vein occlusion (RVO) in Italy. One hundred and fifity-two treatment-naïve and 50 pretreated patients were enrolled...

Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 2)

1 February 2022 | | EYE - General
Are we doing enough to meet the current demands on ophthalmic services? In part two of a two-part series (see Part 1 here), Rosalind Harrison explains how efficiency can be improved by setting up eye services in community hubs. The...

Modern practice options for UK ophthalmologists

4 December 2024 | | EYE - Cataract, EYE - Refractive, EYE - General
When I spoke on setting up private practice at the annual United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in November ’23 there was a lot of interest in different types of practice models. If we...

What not to miss in neuro-ophthalmology Part 2

1 August 2018 | EYE - Neuro-ophthalmology
As mentioned previously there are several conditions in neuro-ophthalmology that should not be missed by the general ophthalmologist as well as ophthalmology trainees. We discussed in the first part some of these conditions including third cranial nerve palsies, giant cell...

Work experience in ophthalmology as an A-Level student

5 September 2023 | | EYE - General
Importance of work experience Medical schools expect applicants to understand what a career in medicine involves, which can be gained through work experience and volunteering. It is strongly recommended by the Medical Schools Council that work experience involves working in...

Cataract care at Staffordshire eye hospital rated ‘outstanding’ by Care Quality Commission

29 May 2023 | spamedica, Cataract surgery, infrastructure
SpaMedica in Newcastle-under-Lyme has been awarded the highest possible rating following a recent inspection by the Care Quality Commission (CQC), the independent regulator of health and social care in England.

‘Class of 2024’ graduate from SpaMedica’s STEPS programme as ophthalmic surgeon celebrates first year teaching trainees to complete over 500 cataract cases

20 December 2024 | STEPs, training, education, industry news, SpaMedica
As the latest ‘Class of 2024’ graduate from SpaMedica’s Training and Education Programme for Surgeons (STEPS), a brand-new cohort of surgical trainees will take up positions at SpaMedica hospitals nationwide. Representing the next generation of ophthalmologists, they will benefit from...

Existential Crises

1 June 2022 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Over the past few years and months, I have noticed increased numbers of my colleagues from all over the UK complaining about various problems with their jobs and life in general, and it seems that since the COVID-19 pandemic the...